4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-23-005268
Head of Pharm Ops and Tech gave up 1,387 shares (to pay taxes)
- Head of Pharm Ops and Tech acquired 2,611 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-10 | Option exercise | +2,271 | 6,379.29 | D | ||
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-10 | Shares withheld for taxes | −685 | $286.30 | $196,116 | 5,694.29 | D |
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-10 | Option exercise | +340 | 6,034.29 | D | ||
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-10 | Shares withheld for taxes | −537 | $286.30 | $153,743 | 5,497.29 | D |
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-10 | Shares withheld for taxes | −165 | $286.30 | $47,240 | 5,332.29 | D |
| Derivatives | |||||||
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-10 | Option exercise · Restricted Stock Unit | −2,271 | 4,544 | D | ||
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-10 | Option exercise · Restricted Stock Unit | −340 | 416 | D | ||
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-10 | Other disposition · Restricted Stock Unit | −416 | 0 | D | ||
Loading xslF345X03/form4.xml…